1,000 fossil-hunters come to Bristol
Over 1,000 paleontologists from all over the world will arrive in Bristol, UK, this week to attend an international conference being held at the University of Bristol.

Over 1,000 paleontologists from all over the world will arrive in Bristol, UK, this week to attend an international conference being held at the University of Bristol.

A screening programme which would require doctors and nurses to ask all women whether they have experienced domestic violence, whatever their reason for seeking medical attention, is not justified, according to a new report by researchers at the University of Bristol, funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme.

Evolution is all about biotic interactions in ecosystems (the Red Queen model), but when seen from further away, the large patterns of biodiversity are driven by the physical environment (the Court Jester model).

A remarkable new discovery shows the four-eyed spookfish to be the first vertebrate ever found to use mirrors, rather than lenses, to focus light in its eyes.

Dan Bailey and Guy Nason, statisticians from the Department of Mathematics, have looked at just how cohesive political parties really are.

Urgent action is needed to safeguard the welfare of pedigree dogs, according to a new independent scientific report commissioned by the RSPCA.

Results from a small research study have pointed the way towards a larger clinical trial of homeopathy for the treatment of atopic dermatitis in dogs.

The economic climate has made Britons more pessimistic about their future financial situation than they were a year ago, reflecting a general international trend towards increased financial anxiety, according to the latest research from the University’s Personal Finance Research Centre (PFRC).

Important progress in understanding the function of tetherin, known to have both anti-cancer and anti-viral properties, has been made by researchers at the University of Bristol.

Apitope announced in 2007 it had developed a vaccine designed to halt multiple sclerosis in its tracks.